CD22-Directed CAR T-Cell Therapy Induces Complete Remissions in CD19-Directed CAR-Refractory Large B-Cell Lymphoma

Overview of attention for article published in Blood, December 2020

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (92nd percentile)
High Attention Score compared to outputs of the same age and source (93rd percentile)

Mentioned by

news: 2 news outlets
twitter: 2 X users
wikipedia: 2 Wikipedia pages

reddit: 1 Redditor
guideline: 1 clinical guideline source

Readers on

mendeley: 88 Mendeley

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 56,923 followers.

CD22-directed CAR T-cell therapy induces complete remissions in CD19-directed CAR–refractory large B-cell lymphoma https://t.co/T2CF1H7RJd https://t.co/eRujLNh8iO

CD22-Directed CAR T-Cell Therapy Induces Complete Remissions in CD19-Directed CAR-Refractory Large B-Cell Lymphoma. #lymphoma #lymsm https://t.co/acyztmEqtw

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity.